Oncotect

🎉 Exciting News in the World of Science! We at Oncotect are thrilled to celebrate the 2024 Nobel Prize winners in Physiology or Medicine for their groundbreaking research in C. elegans. Their work has brought incredible insights into the biological processes that underpin health and disease. At Oncotect, we share a deep appreciation for C. elegans, a model organism we also use in our innovative approach to early cancer detection in dogs. Just as these Nobel laureates have harnessed the power of C. elegans to unlock new medical breakthroughs, we’re leveraging this same tiny organism to develop a cutting-edge, non-invasive screening test for canine cancer. Their research highlights the vast potential of C. elegans in advancing health, and we're proud to be part of a community that’s making strides toward better outcomes for both humans and animals. Here’s to a future where groundbreaking science continues to transform lives—human and canine alike! 🧬🐾 #NobelPrize2024 #CancerDetection #AnimalHealth #CElegans #VeterinaryInnovation #Oncotect #PetCare #EarlyDetection #ScientificBreakthroughs https://lnkd.in/eFU7DuZf

We are excited that our CEO/Founder, Chan Namgong is participating as a competitor at Connect: Pet Tech, a pitch competition designed to bring together leading media members with startups in the pet tech space. Confirmed Media Judges include journalists and contributors from INC Magazine, TechCrunch, Entrepreneur Magazine, The Tech Panda News, and more! If you're interested in attending, supporting these exceptional entrepreneurs, asking questions to the media panel, and connecting with industry professionals, you can register for FREE through this link: https://lnkd.in/gkCx_WVh

Want to meet the future rockstars of the companion animal space? Our Innovation Showcase finalists took to the stage to present their products and advancements this afternoon. Filip Fogdestam, CEO, Alertix Veterinary Diagnostics Natacha Gaillard, Co-Founder & Co-CEO & @Ashwani Sharma, Co-CEO, ASTRA Therapeutics Nayoung Susie K., CEO & Co-Founder, Highfive Vet Benjamin Seidman, Co-Founder, Mella Pet Care Chan Namgong, CEO & Founder, Oncotect Theresa (Terry) W Fossum, CEO & Founder, Phoenix Animal Wellness (PAW) Ashley Kalinauskas, CEO & Founder, Torigen, Inc. @Dina Majzoub, Founder & CEO, Vidapaw AI

Excited to share that Dr. Wages, alongside our CEO, Chan Namgong, had the opportunity to discuss Oncotect's innovative cancer screening test for dogs in an insightful interview with DogCancer.com, LLC. Dive into the conversation to explore the groundbreaking advancements we're bringing to canine health. Don't miss out on this interview! https://lnkd.in/gj5b9q3z

We're thrilled to announce that Oncotect has been selected as a finalist at the Animal Health, Nutrition & Technology Innovation Europe 2024! This recognition is a testament to our team's hard work and dedication to revolutionizing early cancer detection in dogs. Being chosen among many innovative contenders (Highfive Vet, AgBoost, Alertix Veterinary Diagnostics AB, ASTRA Therapeutics, BioAZ, Dalan Animal Health, Inc., EnsiliTech, Torigen, Inc., Vytelle, ArkVax, Quantcom Biosciences, Phoenix Animal Wellness, Modulant Biosciences) highlights the impact and importance of our mission. We're excited for the opportunity to showcase our breakthrough technology and are deeply committed to improving the lives of pets and their families. Thank you to everyone who has supported us on this journey. Let's continue to make strides in animal health together! #AnimalInnovationEurope2024 #Oncotect #VeterinaryInnovation

In this episode of the Veterinary Innovation Podcast, Shawn Wilkie and Dr. Ivan Zakharenkov talk with Chan Namgong, the CEO and Founder of Oncotect, about innovative and affordable at-home cancer screening tests for dogs. Chan shares his personal experience with his mother's battle with cancer, which served as the catalyst for creating an accessible and convenient cancer screening test for dogs. Click the link below: https://lnkd.in/emZ5NMkp

We're thrilled to share that Oncotect has been featured in Today's Veterinary Practice as a leading cancer screening test for dogs. What sets us apart is that Oncotect is the only option directly available to both veterinarians and pet parents. We are committed to providing the most accessible, convenient, and affordable cancer screening solution in the industry. It’s an honor to be recognized for our efforts to enhance canine health and well-being. #VeterinaryCare #CanineHealth #CancerScreening #Oncotect #PetCare https://lnkd.in/egiBc_nq

Check out our CEO's interview with The Woof Canine cancer screening is becoming more accessible and affordable! https://lnkd.in/gYk3Vxjr